Cancer Vaccine Development
Immunotherapy of glioblastoma multiforme stimulates CTL reaction
Published in Proteomics Weekly, November 14th, 2005
"Glioblastoma multiform (GBM) is the most common highly malignant brain tumor and is also one among the most therapy-resistant human neoplasias. At the University Hospital in Lund, a group of patients with GBM were treated with a new therapy form attempting immunization by glioma cells transfected to produce interferon-gamma. The purpose of this report was to evaluate tumor material from the first nine patients treated with this therapy, assessing the levels of inflammatory/reactive cells (lymphocytes and macrophages)," scientists in Sweden report.
"Tumor...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2005-11-14)
More Articles from Proteomics Weekly
- Apoptosis
Ceramide activates a mitochondrial p38 mitogen-activated protein kinase - Proteomics
Chaperone-like activity of MTB Hsp16.3 does not require its intact structures - Proteomics
P-gp expression, but not BCRP, upregulated in early pregnancy to protect fetus - Proteomics
Proteomics of rheumatology are analyzed - Allergy & Immunology
Mnks role in cytokine regulation indicates value as new anti-inflammatory target - Allergy Medicine
Recent findings in allergy medicine provide new insights - More from this issue of Proteomics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
